A ceremony was held in Vientiane capital of Laos on April 29 to hand over and repatriate three sets of remains of Vietnam’s volunteer soldiers and experts who laid down their lives while performing the international duties in Laos.
VOV.VN - Nanogen Pharmaceutical Biotechnology JSC have announced plans to launch the third phase of human trials for its locally-produced coronavirus vaccine Nano Covax on May 5, a timeframe which is three months ahead of schedule.
VOV.VN - A total of six volunteers on April 12 were given their second shot of the domestically-produced novel coronavirus (COVID-19) vaccine known as COVIVAC, which is being developed by the Institute of Vaccines and Medical Biologicals (IVAC).
VOV.VN - Deputy Prime Minister Vu Duc Dam was given a second shot of the locally-produced Nano Covax novel coronavirus (COVID-19) vaccine as part of the second stage of human trials on March 26.
VOV.VN - Up to 26 volunteers received their second shots of the Nano Covax novel coronavirus (COVID-19) vaccine on March 25 at the Vietnam Military Medical University in Hanoi as part of the second-stage of human trials to test the domestically-produced vaccine.
VOV.VN - An additional 30 volunteers participating in human trials for Covivac, the second locally-produced novel coronavirus (COVID-19) vaccine, are due to be given the first shot on March 23 and 25.
VOV.VN - The initial six volunteers participating in human trials of Covivac, the second locally-produced COVID-19 vaccine, remain in stable condition after receiving a dose of the experimental vaccine on March 15.
VOV.VN - Five Vietnamese volunteers who received jabs as part of the national rollout of the AstraZeneca vaccine against COVID-19 have experienced several side-effects, according to the Ministry of Health.
VOV.VN - The second phase of human trials for the locally-produced Nano Covax vaccine against COVID-19 were launched on the morning of February 26, following the completion of the first phase to prove the vaccine’s safety.
VOV.VN - A group of three volunteers are set to receive the first shot of a 75mcg dose of the Nanocovax vaccine on January 18, the highest quantity of the vaccine which will be trialed on participants.